Table 3 Patient characteristics in the two groups according to whether renorrhaphy was performed or not after propensity score matching.

From: Impact of platelet-lymphocyte ratio after robot-assisted partial nephrectomy with renorrhaphy

 

Renorrhaphy group

Omitted group

P

Number of patients (%)

253 (50.0)

253 (50.0)

-

Age (year, median, IQR)

66.0 (54.0–74.0)

65.8 (55.0–72.0)

0.687

Sex (number, %)

0.779

 Male

164 (64.8)

168 (66.4)

 Female

89 (35.2)

85 (33.6)

Body mass index (median, IQR)

24.7 (22.0–27.1)

24.5 (22.0–27.0)

0.952

ECOG-PS (number, median, IQR)

0 (0–0)

0 (0–0)

0.868

Clinical tumor stage

> 0.999

 T1a

243 (96.1)

242 (95.7)

 T1b

10 (4.0)

11 (4.3)

Tumor size (mm, median, IQR)

21.0 (17.0–28.0)

21.0 (16.0–28.0)

0.498

R.E.N.A.L nephrometry score

(number, median, IQR)

6.0 (5.0–7.0)

6.0 (5.0–7.0)

0.371

Preoperative hemoglobin

(g/dL, median, IQR)

14.0 (12.9–15.0)

14.0 (12.9–15.0)

0.892

Preoperative CRP (mg/dL, median, IQR)

0.06 (0.03–0.13)

0.06 (0.03–0.14)

0.834

Preoperative NLR (median, IQR)

2.1 (1.5–2.9)

2.2 (1.7–2.9)

0.391

Preoperative PLR (median, IQR)

138.4 (106.3–174.9)

143.2 (113.7–180.9)

0.102

  1. IQR interquartile range, ECOG-PS Eastern Cooperative Oncology Group Performance Status, CRP c-reactive protein, NLR neutrophil lymphocyte ratio, PLR platelet lymphocyte ratio.